Cargando…
Fludarabine-mediated suppression of the excision repair enzyme ERCC1 contributes to the cytotoxic synergy with the DNA minor groove crosslinking agent SJG-136 (NSC 694501) in chronic lymphocytic leukaemia cells
In this study, we set out to establish whether fludarabine could enhance the DNA interstrand crosslinking capacity of SJG-136 in primary human chronic lymphocytic leukaemia (CLL) cells and thereby offer a rationale for its clinical use in combination with SJG-136. SJG-136 rapidly induced DNA crossli...
Autores principales: | Pepper, C, Lowe, H, Fegan, C, Thurieau, C, Thurston, D E, Hartley, J A, Delavault, P |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360304/ https://www.ncbi.nlm.nih.gov/pubmed/17579621 http://dx.doi.org/10.1038/sj.bjc.6603853 |
Ejemplares similares
-
The XPF-ERCC1 endonuclease and homologous recombination contribute to the repair of minor groove DNA interstrand crosslinks in mammalian cells produced by the pyrrolo[2,1-c][1,4]benzodiazepine dimer SJG-136
por: Clingen, Peter H., et al.
Publicado: (2005) -
Activity of the DNA minor groove cross-linking agent SG2000 (SJG-136) against canine tumours
por: Mellinas-Gomez, Maria, et al.
Publicado: (2015) -
XPF–ERCC1: Linchpin of DNA crosslink repair
por: McHugh, Peter J.
Publicado: (2020) -
A novel Cdk9 inhibitor preferentially targets tumor cells and synergizes with fludarabine
por: Walsby, Elisabeth, et al.
Publicado: (2013) -
The Hsp90 inhibitor NVP-AUY922-AG inhibits NF-κB signaling, overcomes microenvironmental cytoprotection and is highly synergistic with fludarabine in primary CLL cells
por: Walsby, Elisabeth, et al.
Publicado: (2012)